Credit Suisse Ag Galapagos Nv Transaction History

Credit Suisse Ag

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$52.3 - $71.59 $686,960 - $940,334	13,135 New	13,135 $733,000
Q1 2020 May 13, 2020	SELL	$143.0 - $274.03 $420,277 - $805,374	-2,939 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$146.12 - $215.82 $22.1 Million - $32.6 Million	-151,092 Reduced 98.09%	2,939 $608,000
Q3 2019 Nov 12, 2019	SELL	$130.44 - $187.64 $2.1 Million - $3.03 Million	-16,131 Reduced 9.48%	154,031 $23.5 Million
Q2 2019 Aug 14, 2019	SELL	$111.45 - $128.93 $3.89 Million - $4.5 Million	-34,937 Reduced 17.03%	170,162 $21.9 Million
Q1 2019 May 14, 2019	BUY	$89.61 - $117.78 $616,875 - $810,797	6,884 Added 3.47%	205,099 $24.2 Million
Q4 2018 Feb 13, 2019	BUY	$87.81 - $110.65 $688,342 - $867,385	7,839 Added 4.12%	198,215 $18.2 Million
Q3 2018 Nov 13, 2018	BUY	$90.63 - $120.22 $5.9 Million - $7.83 Million	65,094 Added 51.96%	190,376 $21.4 Million
Q2 2018 Aug 14, 2018	SELL	$88.4 - $105.34 $5.05 Million - $6.01 Million	-57,087 Reduced 31.3%	125,282 $11.5 Million
Q1 2018 May 15, 2018	BUY	$94.51 - $120.23 $8.24 Million - $10.5 Million	87,174 Added 91.57%	182,369 $18.2 Million
Q4 2017 Feb 14, 2018	BUY	$84.48 - $104.02 $5.33 Million - $6.56 Million	63,111 Added 196.71%	95,195 $8.93 Million
Q3 2017 Nov 14, 2017	BUY	$73.17 - $103.47 $298,826 - $422,571	4,084 Added 14.59%	32,084 $3.26 Million
Q2 2017 Aug 14, 2017	BUY	N/A	28,000	28,000 $2.14 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.